儿童1型糖尿病:技术对并发症和预期寿命的机制和影响
Flavia Urbano1, Ilaria Farella2, Giacomina Brunetti3
1Giovanni XXIII Pediatric Hospital, 70126 Bari, Italy.
International journal of molecular sciences
|August 12, 2023
概括
自动化胰岛素输送系统显著改善了1型糖尿病 (T1D) 儿童的血糖控制和生活质量. 这些先进技术有助于管理T1D,减少长期并发症.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 生物医学工程 生物医学工程
- 糖尿病 技术 技术
背景情况:
- 1型糖尿病 (T1D) 是一个不断增长的儿童慢性疾病,需要终身管理.
- 严格控制血糖是预防T1D相关并发症和死亡的关键.
- 目前的T1D管理影响儿童的生活质量,因为不断监测和胰岛素的管理.
研究的目的:
- 审查当前用于儿童T1D管理的技术.
- 探索这些技术对糖尿病相关并发症的影响.
- 评估儿童T1D患者对生活质量和预期寿命的影响.
主要方法:
- 关于自动化胰岛素输送系统 (AID) 的文献综述.
- 持续皮下胰岛素输注 (CSII) 和持续血糖监测 (CGM) 整合的分析.
- 检查儿科糖尿病护理的技术进步.
主要成果:
- 辅助系统,包括智能手机连接的CSII和CGM,增强了T1D儿童的代谢控制.
- 这些技术在缓解与糖尿病相关的短期和长期并发症方面表现有前途.
- 改善血糖控制对年轻患者的生活质量产生积极影响.
结论:
- 先进的AID系统为儿科T1D提供了治疗优势.
- 技术整合是优化儿童T1D管理的关键.
- 进一步的研究应该集中在这些不断发展的技术的长期结果和预期寿命上.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Diabetes: Management and Pharmacotherapy
311
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
311
Diabetes: Symptoms, Diagnosis, and Complications
590
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
590
Pathophysiology of Diabetes
989
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
989
Insulin: Dosing Regimen and Adverse Effects
207
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
207


